Geigert. (2013). The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics (2.). Springer New York.
Chicago Style (17th ed.) CitationGeigert. The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics. 2. Springer New York, 2013.
MLA (8th ed.) CitationGeigert. The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics. 2. Springer New York, 2013.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.